Literature DB >> 3681385

Brain metastases from ovarian cancer.

J Ziegler1, P Gliedman, D Fass, M Beckman, A Neophytides, A Steinfeld.   

Abstract

Brain metastasis from ovarian carcinoma is a relatively rare phenomenon. At NYU Medical Center five patients were treated for this entity from 1982 to 1985. The stage at presentation ranged from stage I to stage III, and all patients had received or were receiving chemotherapy. Two patients had active disease elsewhere at diagnosis of brain metastasis, but three patients were otherwise NED. Three patients had solitary cerebellar disease, and two patients had multiple lesions. All patients were treated with whole brain radiotherapy to 3,000 cGy, with neurological improvement in three of the five patients. The central nervous system may need special consideration for prophylactic treatment in those patients with ovarian cancer who receive adjuvant chemotherapy.

Entities:  

Mesh:

Year:  1987        PMID: 3681385     DOI: 10.1007/bf00151224

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  7 in total

1.  Intracranial metastases.

Authors:  P RICHARDS; W McKISSOCK
Journal:  Br Med J       Date:  1963-01-05

2.  THE FUNCTION OF THE VERTEBRAL VEINS AND THEIR ROLE IN THE SPREAD OF METASTASES.

Authors:  O V Batson
Journal:  Ann Surg       Date:  1940-07       Impact factor: 12.969

3.  Radiotherapy in the management of cerebral secondaries from bronchial carcinoma.

Authors:  T J Deeley; J M Edwards
Journal:  Lancet       Date:  1968-06-08       Impact factor: 79.321

4.  Intracranial metastases and their neurosurgical treatment.

Authors:  R G Vieth; G L Odom
Journal:  J Neurosurg       Date:  1965-10       Impact factor: 5.115

5.  Involvement of the central nervous system in patients with ovarian carcinoma.

Authors:  G H Barker; J Orledge; E Wiltshaw
Journal:  Br J Obstet Gynaecol       Date:  1981-07

6.  Treatment of advanced ovarian cancer with cisplatin, adriamycin, and cyclophosphamide: effect of treatment and incidence of intracranial metastases.

Authors:  G T Budd; K D Webster; R R Reimer; P Martimbeau; R B Livingston
Journal:  J Surg Oncol       Date:  1983-11       Impact factor: 3.454

7.  Central nervous system involvement by ovarian carcinoma: a complication of prolonged survivial with metastatic disease.

Authors:  R J Mayer; R S Berkowitz; C T Griffiths
Journal:  Cancer       Date:  1978-02       Impact factor: 6.860

  7 in total
  4 in total

1.  Solitary cerebral metastasis from ovarian carcinoma: report of 4 cases.

Authors:  M Salvati; L Cervoni
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

2.  Solitary cerebral metastases from ovarian epithelial carcinoma: 11 cases.

Authors:  Giancarlo D'Andrea; Raffaelino Roperto; Lavinia Dinia; Emanuela Caroli; Maurizio Salvati; Luigi Ferrante
Journal:  Neurosurg Rev       Date:  2004-11-19       Impact factor: 3.042

3.  Stereotactic radiosurgery in the treatment of brain metastases from gynecologic primary cancer.

Authors:  Hannah Johnston; Emory R McTyre; Cristina K Cramer; Glenn J Lesser; Jimmy Ruiz; J Daniel Bourland; Kounosuke Watabe; Hui-Wen Lo; Shadi Qasem; Adrian W Laxton; Stephen B Tatter; Michael D Chan
Journal:  J Radiosurg SBRT       Date:  2017

4.  Brain metastases from ovarian carcinoma.

Authors:  Ettie Piura; Benjamin Piura
Journal:  ISRN Oncol       Date:  2011-12-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.